These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 3039621)

  • 1. Effect of acyclovir on the replication of turkey herpesvirus and Marek's disease virus.
    Samorek-Salamonowicz E; Cakala A; Wijaszka T
    Res Vet Sci; 1987 May; 42(3):334-8. PubMed ID: 3039621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new serotype of Marek's disease herpesvirus.
    von Bülow V; Biggs PM; Frazier JA
    IARC Sci Publ (1971); 1975; (11 Pt 2):329-36. PubMed ID: 66180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple in vitro differentiation between turkey herpesvirus and Marek's disease virus.
    Cho BR
    Avian Dis; 1981; 25(4):839-46. PubMed ID: 6279072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marek's disease virus (Kekava strain) replication in chickens, chick embryos and cell cultures.
    Yakovleva LS; Mazurenko NP; Gunenkova NK; Vinogradov VN; Pavlovskaya AI; Chernyakhovskaya IY
    Acta Virol; 1975 Jul; 19(4):293-8. PubMed ID: 241226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of izatizon and OL-56 on the reproductive and transformational properties of Marek's disease virus].
    Kudriavtsev FS; Solov'ev IuV; Korovin RN; Shurchilov AF
    Veterinariia; 1977; (2):45-6. PubMed ID: 191986
    [No Abstract]   [Full Text] [Related]  

  • 9. Notes on the mechanism of postvaccination immunity in Marek's disease.
    Yakovleva LS; Mazurenko NP
    Neoplasma; 1977; 24(4):387-94. PubMed ID: 198688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of turkey herpesvirus and Marek's disease virus in chick embryo skin organ culture.
    Prasad LB
    Res Vet Sci; 1979 Jul; 27(1):82-8. PubMed ID: 228368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent inhibition of virus rescue from lymphocytes latently infected with turkey herpesvirus or Marek's disease virus.
    Calnek BW; Shek WR; Schat KA; Fabricant J
    Avian Dis; 1982; 26(2):321-31. PubMed ID: 6285880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activity of cytosine arabinoside on Marek's disease virus.
    Benda V
    Folia Biol (Praha); 1982; 28(5):311-6. PubMed ID: 6293895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiplication, interference, and interferon induction of avian herpesviruses. Contribution to the vaccination against Marek's disease. 2. Materials and methods, results, discussion and conclusion].
    Kaleta EF
    Zentralbl Veterinarmed B; 1977 Jun; 24(6):429-75. PubMed ID: 196461
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition.
    Djeraba A; Bernardet N; Dambrine G; Quéré P
    Virology; 2000 Nov; 277(1):58-65. PubMed ID: 11062036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phosphonoacetate on Marek's disease virus replication.
    Lee LF; Nazerian K; Leinbach SS; Reno JM; Boezi JA
    J Natl Cancer Inst; 1976 Apr; 56(4):823-7. PubMed ID: 176410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marek's disease virus and herpesvirus of turkey noninfective to chickens, obtained by repeated in vitro passages.
    Konobe T; Ishikawa T; Takaku K; Ikuta K; Kitamoto N; Kato S
    Biken J; 1979 Sep; 22(3):103-7. PubMed ID: 231437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of virus-induced antigens from cells infected with marek's disease and turkey herpesviruses.
    Kaaden OR; Dietzschold B
    IARC Sci Publ (1971); 1975; (11 Pt 2):337-44. PubMed ID: 66181
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-specific antiviral activity of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) against Marek's disease herpesvirus and turkey herpesvirus.
    Schat KA; Schinazi RF; Calnek BW
    Antiviral Res; 1984 Oct; 4(5):259-70. PubMed ID: 6097179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of mycostatin on the plaque formation by Marek's disease herpesvirus.
    Cho BR; Bryson WR
    Am J Vet Res; 1973 Sep; 34(9):1211-2. PubMed ID: 4747044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.